comparemela.com

Latest Breaking News On - Victor levitsky - Page 1 : comparemela.com

Circio debuts proof-of-concept for circVec gene therapy at ASGCT 2024

Circio debuts proof-of-concept for circVec gene therapy at ASGCT 2024
biopharma-reporter.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from biopharma-reporter.com Daily Mail and Mail on Sunday newspapers.

United-states
Victor-levitsky
Thomas-hansen

Circio : Annual Report 2023 Report - MarketScreener

Annual Report 2023 25 April 2024 Annual Report.

Norway
Stockholm
Sweden
Washington
United-states
China
Brussels
Bruxelles-capitale
Belgium
Georgetown-university
District-of-columbia
Kansas

Targovax to present at upcoming conferences

/PRNewswire/ Targovax ASA today announces that members of its executive management team are invited to present and participate in upcoming conferences..

Norway
United-kingdom
Prnewswire-targovax-asatoday
Oystein-soug
Victor-levitsky
Andreas-tinglum
Renate-birkeli
Erik-digman-wiklund
Gen-immuno
Corporate-communications-norway
Life-science-investor
Lone-ottesen

Targovax to present at the 4th Annual Next Gen Immuno-oncology Virtual Congress-US Edition

Share this article OSLO, Norway, June 28, 2021 /PRNewswire/ Targovax ASA, today announces that Victor Levitsky, Chief Scientific Officer of Targovax, is invited to present at the 4th Annual Next Gen Immuno-Oncology Virtual Congress-US Edition. 4th Annual Next Gen Immuno-Oncology Virtual Congress-US Edition, virtual Date: 29 June 2021

Norway
Oystein-soug
Prnewswire-targovax
Victor-levitsky
Andreas-tinglum
Gen-immuno
Renate-birkeli
Kim-sutton-golodetz
Corporate-communications-norway
Chief-scientific-officer
Annual-next-gen-immuno-oncology-virtual
Sutton-golodetz

Reminder: Invitation to Targovax's Capital Markets Day 18 February 2021

Share this article OSLO, Feb. 18, 2021 /PRNewswire/ Targovax ASA, a clinical stage immuno-oncology company developing immune activators to target hard-to-treat solid tumors, will host a virtual Capital Markets Day for investors, analysts and journalists today at 2:30 PM CET. The Capital Markets Day will feature presentations from executive management and Alexander Shousthari, Clinical Director Melanoma Services at Memorial Sloan Kettering Cancer Center, and will be webcast live and accessible at https://www.targovax.com/en/capital-markets-day-2021/ Based on the strong clinical data that are now generated on ONCOS-102, Targovax has a solid fundament to move into late stage clinical development. We also have a broader pipeline of preclinical assets that could create a broader horizon of opportunities in the future. The Capital Markets day will feature presentations updating the market on these aspects.

Norway
Alexander-shousthari
Victor-levitsky
Alexander-shoushtariis
Andreas-tinglum
Alexandern-shoushtari
Prnewswire-targovax
Renate-birkeli
Kim-sutton-golodetz
Corporate-communications-norway
Melanoma-services
Memorial-sloan-kettering-cancer-center

vimarsana © 2020. All Rights Reserved.